Literature DB >> 10983507

Two patients with acute intermittent porphyria treated with nafarelin to prevent menstrual exacerbations.

S J McNulty1, K J Hardy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10983507      PMCID： PMC1298087          DOI： 10.1177/014107680009300811

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Immune deficiency in family members of patients with Hodgkin's disease.

Authors:  K Merk; M Björkholm; O Tullgren; H Mellstedt; G Holm
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

2.  Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone.

Authors:  K E Anderson; I M Spitz; S Sassa; C W Bardin; A Kappas
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

3.  Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha.

Authors:  J A Sparano; J P Dutcher; R Kaleya; G Caliendo; J Fiorito; S Mitsudo; R Shechner; S J Boley; R Gucalp; N Ciobanu
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860
  3 in total
  1 in total

1.  Clinical manifestations and diagnostic challenges in acute porphyrias.

Authors:  Henry Trier; Vikram P Krishnasamy; Pashtoon Murtaza Kasi
Journal:  Case Rep Hematol       Date:  2013-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.